SCHEMBL6567726

SCHEMBL6567726

COc1ccc(NC(=O)Nc2ccc(OC(c3ccc(F)cc3)c3cccc(Cl)c3)c(C(=O)O)c2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.51
KDM4E B2RXH2 2/20 0.51
POLB P06746 1/20 0.46
TP53 P04637 1/20 0.44
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
GRIK1 P39086 4/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ATM Q13315 1/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6566633 0.93 MEN1 (0.49) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6566753 0.92 RAB9A (0.47) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6711898 0.92 KMT2A (0.49) MAPTKDM4ETP53MEN1KMT2A
SCHEMBL6565985 0.91 MAPT (0.46) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6564812 0.91 RAB9A (0.48) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6567699 0.90 MAPT (0.48) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6566572 0.89 POLB (0.43) MAPTKDM4EPOLBTP53MEN1
SCHEMBL6567855 0.87 MEN1 (0.53) MAPTKDM4EPOLBMEN1KMT2A
SCHEMBL6710591 0.87 KMT2A (0.50) MAPTKDM4ETP53MEN1KMT2A
SCHEMBL6565775 0.85 IDO1 (0.45) MAPTKDM4ETP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MAPT 4743/4885KDM4E 2962/4885POLB 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.